Logo

Foundation Medicine

Foundation Medicine Test Nabs FDA Approval as CDx for BRAF Inhibitor Therapeutics for Melanoma

FoundationOneCDx will also automatically be a companion diagnostic for future BRAF inhibitors approved by the FDA that target specific BRAF mutations.

New Products Posted to GenomeWeb: Roche, Jumpcode Genomics, Mikrogen, More

People in the News: New Appointments at Grail, Foundation Medicine, Personalis, More

Foundation Medicine, Science 37 Partner to Develop Home-Based Clinical Trial Model

Foundation will identify patients that may be eligible for clinical trials, and Science 37 will enroll them and provide ongoing support.

Foundation Medicine, Epic Ink Deal to Integrate Genomic Tests Into EMR Network

The integration is intended to support oncology practices, academic medical centers, and other health systems by providing access to clinical and genomic info.

Aug 6, 2021

People in the News: New Appointments at Guardant Health, Foundation Medicine, PGDx, GenapSys, More

Jul 16, 2021

FDA Approves Foundation Medicine's Liquid Biopsy Test as CDx for Novartis' Tabrecta in NSCLC

Jul 1, 2021

FDA Approves FoundationOne CDx for Takeda's ALK-Inhibitor

May 21, 2021

Guardant Health to License IP to Foundation Medicine for $25M, Royalties Under Settlement Agreement

Mar 9, 2021

Foundation Medicine, InformedDNA Partner to Expand Genetic Counseling for Cancer Patients

Jan 22, 2021

People in the News: New Appointments at Foundation Medicine, Sophia Genetics, Circulogene; More

Dec 9, 2020

Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project

Nov 18, 2020

Foundation Medicine Licenses Mutation Detection Technology From TwinStrand Biosciences

Nov 17, 2020

Diagnostics Firms, Lab Providers Form Genomic Profiling Coalition

Nov 9, 2020

FDA Approves Foundation Medicine Liquid Biopsy Test as CDx for Lynparza

Nov 2, 2020

Regulatory Documents for Newly Approved Liquid Biopsy NGS Panels Detail Diverse Test Claims, Methods
Premium

Oct 27, 2020

FDA Approves Foundation Medicine Liquid Biopsy Test as CDx for Three Targeted Therapies

Oct 26, 2020

FDA Approves Foundation Medicine CDx, Bayer's Vitrakvi for NTRK Patients

Sep 18, 2020

Foundation Medicine, Takeda Collaborate to Develop CDx for NSCLC Therapies

Sep 16, 2020

Startup Stitch Bio Bets on CRISPR Tech to Render Cancer Cells With Gene Fusions Druggable
Premium

Aug 28, 2020

Stakeholders Scramble to Predict Impact of HHS Move Limiting FDA Ability to Regulate LDTs
Premium

Aug 27, 2020

Foundation Medicine Liquid Biopsy Gets FDA Approval for Multiple Companion Diagnostic Indications

Aug 17, 2020

Foundation Medicine, OneOncology Partner to Bring Precision Oncology to Community Practices

Aug 5, 2020

TargetCancer Foundation Initiates Precision Medicine Study for Rare Cancers

Jul 24, 2020

TMB Harmonization Effort Yields Calibration Method to Correct Inter-Assay Variation
Premium

Breaking News
The Scan

Omicron's Sewage Path

The New York Times writes that testing sewage is helping public health officials track Omicron.

IBM Sells Part of Watson Health

The Wall Street Journal reports IBM is selling part of its Watson Health business to an investment firm.

Identifying the Right Whales

The Boston Globe writes that genetic testing has helped identify North American right whales and find that weaning can take place earlier than thought.

Science Papers on Approach to Quickly Sort Single Cells, Alternative Splicing in Cancer

In Science this week: high-speed sorting of single cells using fluorescence imaging, and more.